Background: The intentional commencement of cervical ripening and uterine contraction for the purpose of achieving delivery prior to the onset of spontaneous parturition is known as induction of labour. When the benefits to the mother or the foetus surpass the benefits of extending the pregnancy, it is indicated. The purpose of this study was to assess the efficacy of a transcervical foley's catheter with extra amniotic saline infusion against intra cervical prostaglandin E2 gel for inducing labour in term pregnant women. Methods: From January 2020 to June 2021, a comparative study was undertaken at R.L. Jalappa Hospital and Research Centre. The study enrolled a total of 72 individuals. After obtaining informed consent from the patients who were admitted, and meeting the inclusion criteria, detailed history was collected, baseline investigations were done. After clinical examination of the patient, by using the simple lottery method, patients were divided into group A (Extra amniotic saline infusion group with Foley’s catheter) and group B (Dinoprostone (PGE2 gel) group). Results: Prolonged gestational age, hypertensive disorders in pregnancy, and oligohydramnios were the most frequent causes for induction in the EASI group, accounting for 38.89%, 38.89%, and 22.22%, respectively. The dinoprostone group has 36.11%, 33.33%, and 25%, respectively. After induction, the majority of patients in the EASI group had a modified Bishop's score of 2. Conclusions: Our research found that PGE2 and EASI were equally effective in inducing labour.
Amenorrhea is the absence of menstrual blood flow. Primary amenorrhea should be considered in a patient with secondary sex characteristics who has not experienced periodic menstruation by 16 years of age or 5 years after breast development. Patients who have not developed secondary sex characteristics, especially the absence of breast development, and have not established periodic menstruation by age 13 should also be worked up for primary amenorrhea1. Turner’s syndrome (TS) also called as Ullrich Turner’s syndrome, is a disease of unclear pathogenesis characterized by complete or partial absence of one sex chromosome, with or without cell line mosaicism in a phenotypic female with short stature and primary ovarian insufficiency. However, TS may also involve other complaints including lymphedema, autoimmune diseases, metabolic diseases, cardiac, kidney and bone anomalies, hearing loss, and neurocognitive difficulties which lead to psychosocial and educational inadaptation. Optimizing health care is crucial to allow these individuals succeed in their full potential. In this regard this is a rare case report of Turner’s syndrome with Mullerian Agenesis.
Background: Normal pregnancy is a procoagulant state. In preeclampsia, this process of coagulation is exaggerated and will lead to further effects on the mother, placenta and fetus. The purpose of this study is to find out the changes that occur in the coagulation indices in pregnancy induced hypertension as compared to that in normal pregnancy which will help in the better management of patients with pregnancy induced Hypertension.Methods: This was a cross sectional study in 116 patients with normotensive and patients with hypertensive disorders in pregnancy conducted in a tertiary medical facility. Coagulation parameters like platelet count, prothrombin time, activated partial thromboplastin time, bleeding time and clotting time were evaluated. We used the difference of 5% in mean PT between normotensive (control) and hypertensive patients by applying 80% power and alpha error of 5%.Results: Platelet counts of study population were significantly related to the prognosis of the patient. The cut off values of major parameters like aPtt, BT with the outcome were with p value of 0.37 and 0.76 respectively.Conclusions: In cases of pregnant complicated with HDP, parameters like coagulation profile, bleeding time, clotting time were probably useful indicators in the early diagnosis and management of severe morbidity of the mother and the fetus. Further prospective trials with large study population are warranted to evident these results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.